Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Disease Modifying Anti-rheumatic Drug (DMARD) But Not Responding.
Clinical trial NCT01197534 · COMPLETED
Trial details
- NCT number
- NCT01197534
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2013-03-01
- Enrollment
- 913
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.